Related Experiment Video
Updated: Mar 24, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
The patient with chronic heart failure undergoing surgery
Valérie Smit-Fun1, Wolfgang F Buhre
1aDepartment of Anesthesiology and Pain Medicine, Maastricht University Medical Center+ bSchool for Mental Health and Neuroscience (MheNS), Faculty of Health, Medicine and Life Sciences, Maastricht University Medical Centre, Maastricht, The Netherlands.
Insights
Congestive heart failure (CHF) significantly increases perioperative risks. Reduced ejection fraction (<30%) is linked to higher mortality and heart attacks, necessitating improved preoperative assessment and tailored therapies.
Area of Science:
- Cardiology
- Anesthesiology
- Geriatrics
Background:
- Congestive heart failure (CHF) is prevalent in elderly patients.
- Approximately 50% of CHF patients have reduced left ventricular ejection fraction.
- Perioperative mortality is elevated in patients with CHF undergoing surgery.
Purpose of the Study:
- Summarize recent literature on CHF and perioperative outcomes.
- Emphasize current guidelines, preoperative assessment, and perioperative therapy.
- Highlight new insights from the past 18 months.
Main Methods:
- Review of recent literature on CHF and perioperative outcomes.
- Analysis of new guidelines from the European Society of Anesthesiology.
- Discussion of risk stratification using parameters like brain natriuretic peptide.
Main Results:
- Ejection fraction <30% is associated with increased mortality and myocardial infarctions.
- Acute heart failure exacerbation occurs in 25% of patients perioperatively.
- New guidelines emphasize preoperative evaluation and risk stratification.
Conclusions:
- CHF contributes significantly to perioperative morbidity and mortality.
- Knowledge regarding CHF in non-cardiac surgery is limited.
- Urgent research is needed to improve perioperative care for CHF patients.
Purpose Of Review:
Congestive heart failure (CHF) is one of the most common diseases of the elderly patient. The underlying pathophysiology varies considerably and approximately 50% of the patients suffer from CHF with reduced left ventricular ejection fraction. Mortality in the perioperative period is increased in patients with CHF and this holds true for both minor and major surgeries. This review will summarize recent literature in the field of CHF and perioperative outcome in patients undergoing surgery with a special emphasis on actual guidelines, preoperative assessment and appropriate perioperative therapy.
Recent Findings:
In the past 18 months, new insights in the short and long-term effects of CHF in the perioperative period have been published. The role of left ventricular ejection fraction has been studied in noncardiac surgical patients and it has been demonstrated that an ejection fraction less than 30% is associated with a significant increase in mortality and myocardial infarctions. Moreover, in 25% of patients, acute exacerbation of heart failure takes place in the perioperative period. The European Society of Anesthesiology published new guidelines on the preoperative evaluation of patients with CHF. The role of adequate preoperative evaluation and preparation of patients with CHF is discussed widely. It becomes clear that parameters like brain natriuretic peptide play a crucial role in risk stratification and prediction of outcome. Also, the treatment of patients with low cardiac output was a topic, and it became clear that established therapies including the use of β-mimetics and PDE-III inhibitors should only be initiated in very selected patient groups. However, adequately powered studies in patients with CHF are still missing and the majority of knowledge is based on patient undergoing cardiac surgery.
Summary:
CHF is a source of considerable perioperative morbidity and mortality and in contrast to coronary artery disease, knowledge is very limited and additional research urgently needed.
Related Concept Videos
Heart Failure V: Medical Management
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Heart Failure VI: Adjunct Therapies
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure I: Introduction

